4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001780081-26-000004
Director sold 33,243 shares at $39.74 ($1,320,964)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Krainer Adrian R. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-10 | Sale : show line 1 in the form 10b5-1 | −33,243 | $39.74 | $1,320,964 | 283,302 | D |
| Open-market sales · 33,243 sh · avg $39.74 · $1,320,964 | ||||||
Loading xslF345X05/form4-03122026_080302.xml…